Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT01394887

Metformin & Inflammation in Pre-diabetic Children

Metformin Decreases Plasma Resistin Concentrations in Pediatric Patients With Impaired Glucose Tolerance: A Placebo-controlled Randomized Clinical Trial

Sponsor: Coordinación de Investigación en Salud, Mexico

Conditions Diabetes Glucose Intolerance Inflammation

Interventions Metformin placebo

Updated 5 times since 2017 Last updated: Jul 15, 2011 Started: Jul 31, 2002 Primary completion: Jul 31, 2003 Completion: Jul 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Diabetes and Glucose Intolerance, this trial is completed. The trial is conducted by Coordinación de Investigación en Salud, Mexico and has accumulated 5 data snapshots since 2002. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Jul 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Coordinación de Investigación en Salud, Mexico

Data source: Coordinación de Investigación en Salud, Mexico

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mexico City, Mexico